Literature DB >> 30207558

Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma.

Kazushi Agata1, Hisashi Kawashima1, Atsushi Kumada1, Yasuyo Kashiwagi1, Hiroko Hara2.   

Abstract

Children with localized scleroderma may have more serious sequelae than adults with the disease. In this case report, we analyzed four girls with localized scleroderma (generalized morphea) to evaluate the clinical usefulness of magnetic resonance imaging in facilitating disease control and investigating patient responsiveness to various treatments. Two of the children had flexion contracture, and two displayed a clear high-intensity area in the bone marrow under the sclerotic skin on magnetic resonance imaging. Two girls had different bilateral circumferences of the legs or forearms. These abnormalities were detected without any obvious changes in blood chemistry. Our results demonstrated that magnetic resonance imaging is useful for the evaluation of treatment effects for localized scleroderma in children.

Entities:  

Keywords:  Localized scleroderma; magnetic resonance imaging; methotrexate; mycophenolate mofetil; osteomyelitis.

Year:  2017        PMID: 30207558      PMCID: PMC6117132          DOI: 10.5606/ArchRheumatol.2018.6498

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  19 in total

1.  Methotrexate and corticosteroid therapy for pediatric localized scleroderma.

Authors:  Y Uziel; B M Feldman; B R Krafchik; R S Yeung; R M Laxer
Journal:  J Pediatr       Date:  2000-01       Impact factor: 4.406

Review 2.  Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases.

Authors:  Hisashi Kawashima; Chiako Watanabe; Yasuyo Kashiwagi; Satoshi Sato; Hiroaki Ioi; Masato Sasamoto; Kouji Takekuma; Yukari Ookubo; Tsunerou Ooi; Akinori Hoshika
Journal:  Pediatr Int       Date:  2006-06       Impact factor: 1.524

3.  Thermography for evaluation of localized scleroderma treated with methotrexate and corticosteroid.

Authors:  Yasuyo Kashiwagi; Hisashi Kawashima; Kazushi Agata; Mai Akaba; Akane Hirose; Soken Go; Shigeo Nishimata; Yoshihito Mitsuhashi; Ryoji Tsuboi
Journal:  Indian J Pediatr       Date:  2013-07-12       Impact factor: 1.967

4.  Localized severe scleroderma: a retrospective study of 26 pediatric patients.

Authors:  Matilde Beltramelli; Paolo Vercellesi; Adina Frasin; Carlo Gelmetti; Fabrizia Corona
Journal:  Pediatr Dermatol       Date:  2010-08-26       Impact factor: 1.588

Review 5.  Classification of morphea (localized scleroderma)

Authors:  L S Peterson; A M Nelson; W P Su
Journal:  Mayo Clin Proc       Date:  1995-11       Impact factor: 7.616

Review 6.  Localized scleroderma in childhood: a report of 30 cases.

Authors:  Y Uziel; B R Krafchik; E D Silverman; P S Thorner; R M Laxer
Journal:  Semin Arthritis Rheum       Date:  1994-04       Impact factor: 5.532

7.  Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.

Authors:  Stefan Schanz; Jörg Henes; Anja Ulmer; Ina Kötter; Gerhard Fierlbeck; Claus Detlef Claussen; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

8.  Pediatric morphea (localized scleroderma): review of 136 patients.

Authors:  Stéphanie Christen-Zaech; Miriam D Hakim; F Sule Afsar; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2008-06-20       Impact factor: 11.527

9.  Localized scleroderma: imaging features.

Authors:  P Liu; Y Uziel; S Chuang; E Silverman; B Krafchik; R Laxer
Journal:  Pediatr Radiol       Date:  1994

10.  Disabling pansclerotic morphea of children.

Authors:  J L Diaz-Perez; S M Connolly; R K Winkelmann
Journal:  Arch Dermatol       Date:  1980-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.